Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive Clinical Benefit of CCM in HFrEF Patients - a win-ratio analysis of FIX-HF-5C randomized trial.

ESC heart failure·2026
Same author

Universal Pulmonary Resistance-Compliance Relationship: And Why It Matters?

Circulation. Heart failure·2026
Same author

JCF In Case You Missed It! Summary of American College of Cardiology (ACC) 2026.

Journal of cardiac failure·2026
Same author

Reflections from the Other Side of the Bed, Part 2.

Journal of cardiac failure·2026
Same author

Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement.

JACC. Heart failure·2026
Same author

Late-Presenting Fulminant Immune Checkpoint Inhibitor Myocarditis Managed With Abatacept and Venoarterial Extracorporeal Oxygenation.

JACC. Case reports·2026

Related Experiment Video

Updated: Aug 22, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K

Temporary mechanical circulatory support devices: practical considerations for all stakeholders.

Benjamin S Salter1, Caroline R Gross2, Menachem M Weiner2

  • 1Department of Anaesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. benjamin.salter@mountsinai.org.

Nature Reviews. Cardiology
|November 10, 2022
PubMed
Summary

Temporary mechanical circulatory support (MCS) devices are now widely used for various procedures, not just life-saving therapy. This review covers their expanding applications, technology, and future development in cardiovascular care.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

748

Related Experiment Videos

Last Updated: Aug 22, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

748

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering

Background:

  • Temporary mechanical circulatory support (MCS) devices, initially for salvage therapy, now have broader clinical applications.
  • Their use has expanded beyond critical care to include catheterization labs, electrophysiology, and operating rooms.

Purpose of the Study:

  • To review the functionality, indications, management, and complications of temporary MCS.
  • To discuss scenario-specific utilization, future device development, and bioengineering.

Main Methods:

  • Comprehensive literature review of temporary mechanical circulatory support (MCS).
  • Synthesis of expert input from interventional cardiology, heart failure, electrophysiology, anesthesiology, critical care, and cardiac surgery.

Main Results:

  • Temporary MCS is increasingly utilized prophylactically and in rescue situations across diverse cardiovascular specialties.
  • Rapid advancements in MCS device design and technology are ongoing.

Conclusions:

  • Temporary MCS plays a crucial role in modern cardiovascular medicine, necessitating a multidisciplinary approach.
  • Future directions involve goal-directed development and bioengineering for improved patient outcomes.